RadNet, Inc.
RDNTHealthcareNASDAQDiagnostics & Research
Scan Results
Daily timeframePart of the healthcare sector, RadNet, Inc. (RDNT) is listed under Diagnostics & Research. The $4.16B market capitalization puts RDNT squarely in mid-cap range for its industry. The company operates in two segments, Imaging Centers and Digital Health.
Market Cap
$4.16B
Beta
1.43
P/E (TTM)
—
P/E (Fwd)
56.07
EPS (TTM)
$-0.17
EPS (Fwd)
$0.94
ROE
1.8%
ROA
1.6%
Cash
$455.3M
Total Debt
$1.93B
Free CF
$190.5M
52W Change
-9.9%
Annual Financials
Cash vs Debt
The company holds $455.3M in cash, though total debt stands at $1.93B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $190.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 1.8%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 1.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.43B (2022) to $2.04B (2025), reflecting a 43% increase over the period.
Investors considering RadNet, Inc. should weigh the typical risks associated with RDNT's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing RDNT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.